Recently, our team demonstrated that upregulated IL-6 is crucial for both inflammatory bowel diseases and CRC development, whereas Th17/T regulatory (Treg) cells and related genes are activated primarily in CRC [14]. Here, IL6 is linked to colorectal carcinoma.